Neuroimaging Through the Course of Alzheimer's Disease

被引:17
|
作者
Smith, Charles D. [1 ]
机构
[1] Univ Kentucky, Rush Alzheimers Dis Ctr, Sanders Brown Ctr Aging,Chandler Med Ctr, Dept Neurol,Magnet Resonance Imaging & Spect Ctr, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; computed tomography; diffusion tensor imaging; FDG; functional imaging; human; magnetic resonance imaging; mild cognitive impairment; morphometry; PIB; positron emission tomography; prediction; review; MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; POSITRON-EMISSION-TOMOGRAPHY; WHITE-MATTER DAMAGE; MEDIAL TEMPORAL ATROPHY; DIFFUSION-TENSOR; BRAIN ATROPHY; DEFAULT-MODE; HIPPOCAMPAL ATROPHY; AMYLOID DEPOSITION;
D O I
10.3233/JAD-2010-1217
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review uses an image-indexed framework for the full course of Alzheimer's disease (AD) to provide a perspective on recent neuroimaging findings in the literature. Modalities considered include morphometric, diffusion tensor, and functional magnetic resonance imaging, and resting/functional metabolic and amyloid-label positron emission tomography. The major focus is on the AD pre-states (normal but high AD risk and mild cognitive impairment), and transition from mild cognitive impairment to mild AD. Imaging results relevant to the conduct of future prevention and early intervention trials are emphasized.
引用
收藏
页码:273 / 290
页数:18
相关论文
共 50 条
  • [21] Neuroimaging biomarkers in Alzheimer's disease and other dementias
    Villemagne, Victor L.
    Chetelat, Gael
    AGEING RESEARCH REVIEWS, 2016, 30 : 4 - 16
  • [22] Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative
    Jack, Clifford R., Jr.
    Bernstein, Matt A.
    Borowski, Bret J.
    Gunter, Jeffrey L.
    Fox, Nick C.
    Thompson, Paul M.
    Schuff, Norbert
    Krueger, Gunnar
    Killiany, Ronald J.
    DeCarli, Charles S.
    Dale, Anders M.
    Carmichael, Owen W.
    Tosun, Duygu
    Weiner, Michael W.
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 212 - 220
  • [23] Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review
    Ruan, Qingwei
    D'Onofrio, Grazia
    Sancarlo, Daniele
    Bao, Zhijun
    Greco, Antonio
    Yu, Zhuowei
    BMC GERIATRICS, 2016, 16
  • [24] Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET
    Matsuda, Hiroshi
    Shigemoto, Yoko
    Sato, Noriko
    JAPANESE JOURNAL OF RADIOLOGY, 2019, 37 (11) : 735 - 749
  • [25] Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications
    Ferreira, Luiz Kobuti
    Busatto, Geraldo F.
    CLINICS, 2011, 66 : 19 - 24
  • [26] Systematic Review of Different Neuroimaging Correlates in Mild Cognitive Impairment and Alzheimer's Disease
    Talwar, Puneet
    Kushwaha, Suman
    Chaturvedi, Monali
    Mahajan, Vidur
    CLINICAL NEURORADIOLOGY, 2021, 31 (04) : 953 - 967
  • [27] Contribution of Neuroimaging to the Diagnosis of Alzheimer's Disease and Vascular Dementia
    Roman, Gustavo
    Pascual, Belen
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (08) : 671 - 676
  • [28] Neuroimaging Modalities in Alzheimer's Disease: Diagnosis and Clinical Features
    Kim, JunHyun
    Jeong, Minhong
    Stiles, Wesley R.
    Choi, Hak Soo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [29] A review of neuroimaging biomarkers of Alzheimer's disease
    Varghese, Tinu
    Sheelakumari, R.
    James, Jija S.
    Mathuranath, P. S.
    NEUROLOGY ASIA, 2013, 18 (03) : 239 - 248
  • [30] Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative
    Grill, Joshua D.
    Di, Lijie
    Lu, Po H.
    Lee, Cathy
    Ringman, John
    Apostolova, Liana G.
    Chow, Nicole
    Kohannim, Omid
    Cummings, Jeffrey L.
    Thompson, Paul M.
    Elashoff, David
    NEUROBIOLOGY OF AGING, 2013, 34 (01) : 62 - 72